BrainStorm Cell Therapeutics
BCLI
#9930
Rank
NZ$17.76 M
Marketcap
$3.11
Share price
15.48%
Change (1 day)
-38.59%
Change (1 year)

Earnings for BrainStorm Cell Therapeutics (BCLI)

Earnings in 2024 (TTM): -NZ$16.19 Million

According to BrainStorm Cell Therapeutics's latest financial reports the company's current earnings are N/A. In 2022 the company made an earning of -NZ$42.25 Million, an increase over its 2021 earnings that were of -NZ$42.57 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for BrainStorm Cell Therapeutics from 2003 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -NZ$16.19 Million
2022 -NZ$42.25 Million-0.74%
2021 -NZ$42.57 Million-23.12%
2020 -NZ$55.36 Million36.8%
2019 -NZ$40.47 Million66.71%
2018 -NZ$24.28 Million181.66%
2017 -NZ$8.62 Million-0.6%
2016 -NZ$8.67 Million-41.31%
2015 -NZ$14.78 Million-8.22%
2014 -NZ$16.1 Million89.74%
2013 -NZ$8.49 Million42.27%
2012 -NZ$5.97 Million-12.45%
2011 -NZ$6.81 Million63.04%
2010 -NZ$4.18 Million35.52%
2009 -NZ$3.09 Million-48.99%
2008 -NZ$6.05 Million-44.39%
2007 -NZ$10.87 Million
2005 -NZ$5.63 Million-91.44%
2004 -NZ$65.75 Million94007.62%
2003 -NZ$0.07 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
NZ$0.30 B-1,882.10%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$1.01 Billion 5,736.39%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$1.38 Billion 7,905.02%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$3.31 B-19,400.32%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$0.17 Billion 840.94%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$0.45 Billion 2,486.97%๐Ÿ‡บ๐Ÿ‡ธ USA